Fig. 6From: Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerThe expression levels of DDIT4 in breast cancer based on different clinical characteristics. *p < 0.05, **p < 0.01, ***p < 0.001Back to article page